Balyasny Asset Management
NVAX icon

Balyasny Asset Management’s Novavax NVAX Stock Holding History

Balyasny Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$775K Buy
+82,240
New +$737K ﹤0.01% 2345
2026
Q1 		– Sell
-384,991
Closed -$2.59M – 3328
2025
Q4 		$2.59M Buy
384,991
+26,864
+8% +$203K ﹤0.01% 1742
2025
Q3 		$3.1M Buy
+358,127
New +$2.79M ﹤0.01% 1601
2023
Q4 		– Sell
-1,380,009
Closed -$9.99M – 2773
2023
Q3 		$9.99M Buy
+1,380,009
New +$11M 0.02% 847
2022
Q4 		– Sell
-19,633
Closed -$357K – 3082
2022
Q3 		$357K Buy
+19,633
New +$851K ﹤0.01% 2137
2022
Q2 		– Sell
-4,367
Closed -$322K – 3043
2022
Q1 		$322K Buy
+4,367
New +$389K ﹤0.01% 1909
2021
Q4 		– Sell
-37,457
Closed -$7.76M – 2494
2021
Q3 		$7.76M Sell
37,457
-47,259
-56% -$10.4M 0.03% 672
2021
Q2 		$18M Buy
84,716
+38,072
+82% +$6.98M 0.09% 317
2021
Q1 		$8.46M Buy
46,644
+20,945
+82% +$4.17M 0.04% 534
2020
Q4 		$2.87M Buy
+25,699
New +$2.73M 0.02% 795
2019
Q1 		– Sell
-27,186
Closed -$1M – 1566
2018
Q4 		$1M Buy
+27,186
New +$1.05M 0.01% 901
2018
Q3 		– Sell
-24,691
Closed -$662K – 1936
2018
Q2 		$662K Buy
24,691
+19,824
+407% +$670K ﹤0.01% 1255
2018
Q1 		$204K Buy
4,867
+2,467
+103% +$99.1K ﹤0.01% 1758
2017
Q4 		$60K Buy
+2,400
New +$58.6K ﹤0.01% 2004
2015
Q4 		– Sell
-709
Closed -$100K – 1380
2015
Q3 		$100K Buy
+709
New +$159K ﹤0.01% 1069

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Balyasny Asset Management's NVAX Position: Q2 2026 in Review

Balyasny Asset Management opened a new position in Novavax (NVAX) in Q2 2026: 82,240 shares worth $775K. The stake represents ﹤0.01% of the portfolio and ranks #2345 among its holdings. This is a return to the name: Balyasny Asset Management previously reported a position in NVAX as recently as Q4 2025.

Balyasny Asset Management first reported a position in NVAX in Q3 2015 and has held it in 15 quarters since. The position peaked at $18M in Q2 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Balyasny Asset Management held 82,240 shares of Novavax worth $775K as of Q2 2026.
  • Novavax was a new Balyasny Asset Management position in Q2 2026.
  • Novavax made up ﹤0.01% of Balyasny Asset Management's portfolio in Q2 2026, its #2345 holding.
  • Balyasny Asset Management first reported a position in Novavax in Q3 2015 and has held it in 15 quarters since.
  • Balyasny Asset Management's Novavax position peaked at $18M in Q2 2021.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.